Treating Lymphoma with Bispecific Antibodies – July 19, 2023


LRF’s free webinars are hour-long interactive programs led by leading lymphoma experts who discuss lymphoma, treatment options, clinical trials, and promising innovative research. Webinars can be listened to live on the telephone or via web streaming. Podcasts of the programs can also be accessed following the live program. Please continue to check this page for updates.

Treating Lymphoma with Bispecific Antibodies

DATE: Wednesday, July 19, 2023
TIME: 4:00 PM – 5:00 PM Eastern Time

VIRTUAL PROGRAM – This is a virtual event, accessible online and over the phone. Access instructions will be provided after registration. Note: Look for Beacon360 as sender of confirmation and reminder emails.


Jennifer Crombie, MD
Medical Oncologist
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School

Lorenzo Falchi, MD
Medical Oncologist
Memorial Sloan Kettering Cancer Center
Assistant Professor
Weill Cornell Graduate School of Medical Sciences

Program Overview

  • Overview and Understanding Bispecific Antibody Therapy
  • When to Consider Bispecific Antibody Therapy as a Treatment Option for Lymphoma
  • Clinical Trials for Bispecific Antibody Therapy
  • Managing Potential Treatment Side Effects and the Role of the Caregiver
  • Follow-Up Care: What to Expect
  • Questions and Answers Session

Ways to Register

VIRTUAL PROGRAM – This is a virtual event, accessible online and over the phone. Access instructions will be emailed after registration. Note: Beacon360 will email confirmation and reminders.

Call: 800-500-9976

This program is for patients and survivors, caregivers and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email to learn more about sponsorship.

Disclaimer: The Lymphoma Research Foundation (LRF) is a national nonprofit organization based in the United States with educational programs and resources are intended for a US-based audience. These program and resources address available lymphoma treatments in the United States. and information on drug approvals by the US Food and Drug Administration.

For individuals outside of the US, LRF recommends the Lymphoma Coalition at The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non US-based audiences.

Program Supporters

This program is supported through unrestricted educational grants from: